雪榕生物公(gong)(gong)告，持公(gong)(gong)司(si)(si)股份28,758,589股（占公(gong)(gong)司(si)(si)總股本(ben)比(bi)例6.51%）的(de)股東余(yu)榮琳計劃(hua)6個月內，通過大(da)宗(zong)交易、集中競價等方式(shi)減持公(gong)(gong)司(si)(si)股份不(bu)超過13,200,000股（即(ji)不(bu)超過公(gong)(gong)司(si)(si)總股本(ben)的(de)2.99%）。